- Home
- BBGI vs ATOS Comparison
BBGI vs ATOS Comparison
Compare BBGI & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBGI | ATOS |
|---|---|---|
| Founded | 1961 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6M | 24.4M |
| IPO Year | 1999 | 2010 |
Fundamental Metrics
Financial Performance| Metric | BBGI | ATOS |
|---|---|---|
| Price | $7.62 | $2.62 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $19.00 |
| AVG Volume (30 Days) | 29.9K | ★ 96.2K |
| Earning Date | 11-09-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 48.01 | N/A |
| Revenue | ★ $232,179,463.00 | $1,758.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.47 | N/A |
| P/E Ratio | $0.17 | ★ N/A |
| Revenue Growth | ★ 69.89 | N/A |
| 52 Week Low | $3.14 | $0.53 |
| 52 Week High | $29.30 | $7.56 |
Technical Indicators
Market Signals| Indicator | BBGI | ATOS |
|---|---|---|
| Relative Strength Index (RSI) | 23.19 | 55.41 |
| Support Level | $7.52 | $2.32 |
| Resistance Level | $24.70 | $3.04 |
| Average True Range (ATR) | 0.96 | 0.28 |
| MACD | 0.09 | 0.02 |
| Stochastic Oscillator | 4.71 | 52.50 |
Price Performance
Historical ComparisonAbout BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA; Augusta, GA; Boston, MA; Charlotte, NC; Detroit, MI; Fayetteville, NC; Fort Myers-Naples, FL; Las Vegas, NV; Middlesex, NJ; Monmouth, NJ; Morristown, NJ; Philadelphia, PA; Tampa-Saint Petersburg, FL; and Wilmington, DE. The company operates in two segments: Audio, which generates the maximum revenue, and Digital.
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.